| Literature DB >> 35535123 |
Mitchel A Muhleman1, Jorge D Oldan1, Amir H Khandani1.
Abstract
We present a case of abnormal findings on a Tc99m-Sestamibi parathyroid scan, post COVID-19 vaccination. The patient is a 48-year-old female presenting for evaluation of hyperparathyroidism who received the mRNA-1273 Moderna (ModernaTX, Inc.) vaccine seven days prior to the scan. The patient is right hand dominant and reported no traumatic events, inflammation, infection, or extraneous use of the left arm. The patient did report "soreness" of the extremity starting approximately 24 hours post injection which continued to the time of the study. AJNMMIEntities:
Keywords: COVID-19 vaccination; Tc99m-Sestamibi increased uptake
Year: 2022 PMID: 35535123 PMCID: PMC9077171
Source DB: PubMed Journal: Am J Nucl Med Mol Imaging